NET PROFIT (x1000 SEK)
EMPLOYEES
Arcedi Biotech ApS
Closing information (x1000 SEK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
![]() |
0
![]() |
0 |
Earnings before taxes |
-62,852
|
-49,737
|
-12,212 |
Total assets |
204,196
|
189,184
|
158,047 |
Current assets |
17,922
|
14,670
|
10,971 |
Current liabilities |
10,697
|
9,461
|
180,993 |
Equity capital |
-127,736
|
-79,801
|
-40,055 |
- share capital |
119
|
120
|
110 |
Employees (average) |
15
![]() |
15
![]() |
15 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
-62.6%
|
-42.2%
|
-25.3% |
Turnover per employee |
0
![]() |
0
![]() |
0 |
Profit as a percentage of turnover | |||
Return on assets (ROA) | |||
Current ratio |
167.5%
|
155.1%
|
6.1% |
Return on equity (ROE) |
49.2%
|
62.3%
|
30.5% |
Change turnover |
0
![]() |
0
![]() |
0 |
Change turnover % | |||
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.